MEI Pharma, Inc. (MEIP:NASDAQ) rocketted at $2.5, representing a gain of 49.7%. On Mon 13 Apr 20, MEIP:NASDAQ touched a New 2-Week Intraday High of $1.73. The stock got featured on our News Catalysts scanner on Tue 14 Apr 20 at 02:18 PM in the 'INVESTOR UPDATE' category. From Mon 30 Mar 20, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About MEI Pharma, Inc. (MEIP:NASDAQ)
MEI Pharma Inc is an oncology company focused on the clinical development of novel therapeutics for cancer. The Company's portfolio of drug candidates includes Pracinostat, an oral histone deacetylase inhibitor.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 139.71%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 61.9%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 61.74%
- NeuroMetrix, Inc. (NURO:NASDAQ), 58.73%
- MEI Pharma, Inc. (MEIP:NASDAQ), 49.7%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 47.06%
- MicroVision, Inc. (MVIS:NASDAQ), 44.68%
- Forestar Group Inc. (FOR:NYSE), 42.17%
- Immutep Limited (IMMP:NASDAQ), 40.77%
- RigNet, Inc. (RNET:NASDAQ), 38.79%